| Date Filed | Type | Description |
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| CAUWENBERGH GEERT (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 03/03/2021 |
4
| CAUWENBERGH GEERT (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2019 |
4
| CAUWENBERGH GEERT (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Paid exercise price by delivering 1,751 shares
@ $0.403, valued at
$705.7 |
|
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2019 |
4
| CAUWENBERGH GEERT (CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 21,470 shares
@ $0.3771, valued at
$8.1k
|
|
| 01/22/2019 |
4
| CAUWENBERGH GEERT (CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 23,729 shares
@ $0.3412, valued at
$8.1k
|
|
| 01/07/2019 |
4
| CAUWENBERGH GEERT (CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 23,139 shares
@ $0.3499, valued at
$8.1k
|
|
| 12/26/2018 |
4
| CAUWENBERGH GEERT (CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 27,445 shares
@ $0.295, valued at
$8.1k
|
|
| 12/10/2018 |
4
| CAUWENBERGH GEERT (CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 21,882 shares
@ $0.37, valued at
$8.1k
|
|
| 11/26/2018 |
4
| CAUWENBERGH GEERT (CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.|
Txns:
| Granted 25,941 shares
@ $0.3121, valued at
$8.1k
|
|
| 11/13/2018 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 18,698 shares
@ $0.433, valued at
$8.1k
|
|
| 10/29/2018 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 18,519 shares
@ $0.4372, valued at
$8.1k
|
|
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2018 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 21,000 shares
@ $0
Granted 21,000 options to buy
@ $1.79, valued at
$37.6k
|
|
| 10/02/2017 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Bought 2,700 shares
@ $0.44, valued at
$1.2k
Bought 200 shares
@ $0.46, valued at
$92
Bought 7,100 shares
@ $0.45, valued at
$3.2k
|
|
| 08/24/2017 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Bought 4,900 shares
@ $0.545, valued at
$2.7k
Bought 4,361 shares
@ $0.55, valued at
$2.4k
Bought 739 shares
@ $0.56, valued at
$413.8 |
|
| 06/22/2017 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Bought 5,000 shares
@ $0.63, valued at
$3.2k
Bought 5,000 shares
@ $0.62, valued at
$3.1k
|
|
| 04/26/2017 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 03/20/2017 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 02/21/2017 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 02/08/2017 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 02/03/2017 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 01/26/2017 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 01/19/2017 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 01/03/2017 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 12/27/2016 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 12/23/2016 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 12/20/2016 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 02/12/2016 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 133,000 options to buy
@ $0.2858, valued at
$38k
|
|
| 06/23/2015 |
4
| CAUWENBERGH GEERT (President & CEO) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Exercised (in-or-at-the-money) 35,000 options to buy
@ $0.455, valued at
$15.9k
|
|
|